Merkel Cell Carcinoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Merkel Cell Carcinoma

What is the definition of Merkel Cell Carcinoma?
Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer. It usually develops as a single, painless, bump on sun-exposed skin. The bump may be skin-colored or red-violet, and tends to grow rapidly over weeks to months. It may spread quickly to surrounding tissues, nearby lymph nodes, or more distant parts of the body. Factors associated with developing MCC include increasing age, fair skin, a history of extensive sun exposure, chronic immune suppression, and the Merkel cell polyomavirus. The Merkel cell polyomavirus has been detected in most people who have MCC.
What are the alternative names for Merkel Cell Carcinoma?
  • Merkel cell carcinoma
  • Carcinoma, merkel cell
  • Cutaneous neuroendocrine carcinoma
  • Merkel cell cancer
  • Merkle tumors
Who are the top Merkel Cell Carcinoma Local Doctors?
Elite in Merkel Cell Carcinoma
Dermatology
Elite in Merkel Cell Carcinoma
Dermatology

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
Languages Spoken:
English
Offers Telehealth

Paul Nghiem is a Dermatologist practicing medicine in Seattle, Washington. Dr. Nghiem is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Eccrine Porocarcinoma, and Melanoma.

Elite in Merkel Cell Carcinoma
Elite in Merkel Cell Carcinoma
221 Longwood Ave, 
Boston, MA 
Languages Spoken:
English

Manisha Thakuria is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Thakuria is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Actinic Keratosis, Warts, and Granuloma Annulare. Dr. Thakuria is board certified in Dermatology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Merkel Cell Carcinoma
Hematology | Hematology Oncology | Oncology
Elite in Merkel Cell Carcinoma
Hematology | Hematology Oncology | Oncology

Swedish Cancer Institute Medical Oncology - Edmonds

21605 76th Avenue West, Suite 200, 
Edmonds, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

"Dr. Paulson is passionate about practicing medical oncology, as it seamlessly integrates cutting-edge scientific advancements with the compassionate essence of medicine. Her clinical interests focus on skin cancer and solid tumor immunotherapy while Dr. Paulson’s appreciation lies in the ability to establish meaningful connections with patients and their families, throughout their care. Dr. Paulson firmly believes that optimal cancer care is achieved through a collaborative, team-based approach and takes great joy in working alongside an interdisciplinary team of dedicated healthcare professionals. Recognizing the pivotal role of patients in their own care, she is committed to transparent communication, ensuring that everyone understands the ""how and why"" behind their personalized treatment plans. In addition to her clinical role, Dr. Paulson is a skilled clinical researcher, serving as the Principal Investigator for various clinical trials aimed at bringing the latest advancements in cancer care and the lead for the Center for Immuno-Oncology at the Paul G Allen Research Center. Furthermore, she is dedicated to nurturing the next generation of medical professionals, actively supporting medical students at the Washington State University Elson E. Floyd Medical School in Everett, particularly in advancing their understanding of emerging immunotherapies. In 2023, Dr. Kelly Paulson was honored as the inaugural recipient of the Jeff Ward Award, established to memorialize him. This distinguished award acknowledges medical staff members who contribute positively to the Edmonds community through exceptional leadership, mentorship, or improvements in patient care. Also, she is a 2024 Castle Connolly Top Doctor. Dr. Paulson sees patients at the Edmonds and First Hill Swedish Cancer Institute locations.". Dr. Paulson is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer. Dr. Paulson is board certified in American Board Of Internal Medicine. Dr. Paulson is currently accepting new patients.

What are the latest Merkel Cell Carcinoma Clinical Trials?
A Phase I/II Study of Pembrolizumab (MK-3475) in Japanese Pediatric Participants With Specific Solid Tumors or Lymphomas, or in Japanese Adult Participants With Advanced Merkel Cell Carcinoma (KEYNOTE-G21)

Summary: Researchers are looking for new ways to treat people with solid tumors, lymphomas (blood cancers), and a certain type of skin cancer. The goals of this study are to learn: * About the safety of pembrolizumab (the study medicine) and if people tolerate it * What happens to different doses of pembrolizumab in a person's body over time * How the cancer responds (gets smaller or goes away) to treatmen...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers

Summary: This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune syst...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center